Regorafenib dose optimization study (ReDOS): Randomized phase II trial to evaluate dosing strategies for regorafenib in refractory metastatic colorectal cancer (mCRC): An ACCRU Network study Meeting Abstract
| Authors: | Bekaii-Saab, T. S.; Ou, F. S.; Anderson, D. M.; Ahn, D. H.; Boland, P. M.; Ciombor, K. K.; Jacobs, N. L.; Desnoyers, R. J.; Cleary, J. M.; Meyers, J. P.; Chiorean, E. G.; Pedersen, K.; Barzi, A.; Sloan, J.; McCune, J. S.; Lacouture, M. E.; Lenz, H. J.; Grothey, A. |
| Abstract Title: | Regorafenib dose optimization study (ReDOS): Randomized phase II trial to evaluate dosing strategies for regorafenib in refractory metastatic colorectal cancer (mCRC): An ACCRU Network study |
| Meeting Title: | 2018 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2018 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000436174100587 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2018.36.4_suppl.611 |
| Notes: | Meeting Abstract: 611 -- Source: Wos |
